View in EDS

Evaluation of disease-free survival as a predictor of overall survival and assessment of real-world burden of disease recurrence in resected early-stage non-small cell lung cancer.

Saved in:
Bibliographic Details
Title: Evaluation of disease-free survival as a predictor of overall survival and assessment of real-world burden of disease recurrence in resected early-stage non-small cell lung cancer.
Authors: West H; City of Hope Comprehensive Cancer Center, Duarte, CA., Hu X; Merck & Co., Inc., Rahway, NJ., Zhang S; Analysis Group, Inc., Boston, MA., Song Y; Analysis Group, Inc., Boston, MA., Chirovsky D; Merck & Co., Inc., Rahway, NJ., Gao C; Analysis Group, Inc., Boston, MA., Lerner A; Analysis Group, Inc., Boston, MA., Jiang A; Analysis Group, Inc., Boston, MA., Signorovitch J; Analysis Group, Inc., Boston, MA., Samkari A; Merck & Co., Inc., Rahway, NJ.
Source: Journal of managed care & specialty pharmacy [J Manag Care Spec Pharm] 2023 Jul; Vol. 29 (7), pp. 749-757.
Publication Type: Observational Study; Journal Article
Journal Info: Publisher: Academy of Managed Care Pharmacy Country of Publication: United States NLM ID: 101644425 Publication Model: Print Cited Medium: Internet ISSN: 2376-1032 (Electronic) Linking ISSN: 23760540 NLM ISO Abbreviation: J Manag Care Spec Pharm Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 37404067
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Evaluation of disease-free survival as a predictor of overall survival and assessment of real-world burden of disease recurrence in resected early-stage non-small cell lung cancer.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22West+H%22">West H</searchLink>; City of Hope Comprehensive Cancer Center, Duarte, CA.<br /><searchLink fieldCode="AU" term="%22Hu+X%22">Hu X</searchLink>; Merck & Co., Inc., Rahway, NJ.<br /><searchLink fieldCode="AU" term="%22Zhang+S%22">Zhang S</searchLink>; Analysis Group, Inc., Boston, MA.<br /><searchLink fieldCode="AU" term="%22Song+Y%22">Song Y</searchLink>; Analysis Group, Inc., Boston, MA.<br /><searchLink fieldCode="AU" term="%22Chirovsky+D%22">Chirovsky D</searchLink>; Merck & Co., Inc., Rahway, NJ.<br /><searchLink fieldCode="AU" term="%22Gao+C%22">Gao C</searchLink>; Analysis Group, Inc., Boston, MA.<br /><searchLink fieldCode="AU" term="%22Lerner+A%22">Lerner A</searchLink>; Analysis Group, Inc., Boston, MA.<br /><searchLink fieldCode="AU" term="%22Jiang+A%22">Jiang A</searchLink>; Analysis Group, Inc., Boston, MA.<br /><searchLink fieldCode="AU" term="%22Signorovitch+J%22">Signorovitch J</searchLink>; Analysis Group, Inc., Boston, MA.<br /><searchLink fieldCode="AU" term="%22Samkari+A%22">Samkari A</searchLink>; Merck & Co., Inc., Rahway, NJ.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101644425%22">Journal of managed care & specialty pharmacy</searchLink> [J Manag Care Spec Pharm] 2023 Jul; Vol. 29 (7), pp. 749-757.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Observational Study; Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Academy+of+Managed+Care+Pharmacy%22">Academy of Managed Care Pharmacy </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101644425 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>2376-1032 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2223760540%22">23760540 </searchLink><i>NLM ISO Abbreviation: </i>J Manag Care Spec Pharm <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=37404067
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.18553/jmcp.2023.29.7.749
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 749
    Titles:
      – TitleFull: Evaluation of disease-free survival as a predictor of overall survival and assessment of real-world burden of disease recurrence in resected early-stage non-small cell lung cancer.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: West H
      – PersonEntity:
          Name:
            NameFull: Hu X
      – PersonEntity:
          Name:
            NameFull: Zhang S
      – PersonEntity:
          Name:
            NameFull: Song Y
      – PersonEntity:
          Name:
            NameFull: Chirovsky D
      – PersonEntity:
          Name:
            NameFull: Gao C
      – PersonEntity:
          Name:
            NameFull: Lerner A
      – PersonEntity:
          Name:
            NameFull: Jiang A
      – PersonEntity:
          Name:
            NameFull: Signorovitch J
      – PersonEntity:
          Name:
            NameFull: Samkari A
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 07
              Text: 2023 Jul
              Type: published
              Y: 2023
          Identifiers:
            – Type: issn-electronic
              Value: 2376-1032
          Numbering:
            – Type: volume
              Value: 29
            – Type: issue
              Value: 7
          Titles:
            – TitleFull: Journal of managed care & specialty pharmacy
              Type: main
ResultId 1